Study reveals significant deficit in the UK’s prosthetic and orthotic workforce

The Uni­ver­si­ty of Illi­nois Chica­go’s Col­lege of Phar­ma­cy last week pe­ti­tioned the FDA to re­move clin­i­cal ef­fi­ca­cy test­ing for all new biosim­i­lars — and not

Aclaris Ther­a­peu­tics’ lead drug has failed an­oth­er mid-stage test, mark­ing the biotech’s sec­ond ma­jor set­back this year and the au­toim­mune treat­ment’s fi­nal shot in the